PACIFIC BIOSCIENCES OF CALIF (PACB) Stock Analyst Earnings Estimates
NASDAQ:PACB - Nasdaq - US69404D1081 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 128.3M -1.69% | 200.521M 56.29% | 154.014M -23.19% | 164.98M 7.12% | 209.24M 26.83% | 253.5M 21.15% | 375.39M 48.08% | 500.11M 33.22% | 580.33M 16.04% | 691.05M 19.08% | 773.87M 11.98% | |
| EBITDA YoY % growth | -293.11M -70.69% | -302.265M -3.12% | N/A 6.04% | -175.207M 38.31% | -139.379M 20.45% | -99.45M 28.65% | -37.74M 62.05% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -303.5M -69.27% | -321.989M -6.09% | -288.815M 10.30% | -205.475M 28.86% | -173.083M 15.76% | -136.048M 21.40% | -84.66M 37.77% | 49.266M 158.19% | 91.137M 84.99% | 90.474M -0.73% | 145.45M 60.76% | |
| Operating Margin | -236.55% | -160.58% | -187.53% | -124.55% | -82.72% | -53.67% | -22.55% | 9.85% | 15.70% | 13.09% | 18.80% | |
| EPS YoY % growth | -1.40 -16.67% | -1.21 13.57% | -0.64 47.11% | -0.75 -17.69% | -0.59 21.12% | -0.46 21.79% | -0.33 29.03% | -0.04 87.63% | N/A | N/A | N/A |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 33.52% | -0.19 70.36% | -0.18 16.08% | -0.18 -134.80% | -0.17 12.04% | -0.16 13.31% | -0.15 17.13% | -0.15 15.23% | -0.16 3.76% | -0.15 6.98% | -0.13 13.33% | -0.13 15.25% |
| Revenue Q2Q % growth | 34.343M -11.51% | 38.982M 8.24% | 43.897M 9.83% | 48.295M 23.13% | 44.396M 29.27% | 48.945M 25.56% | 54.238M 23.56% | 58.968M 22.10% | 51.561M 16.14% | 58.456M 19.43% | 70.747M 30.44% | 79.427M 34.70% |
| EBITDA Q2Q % growth | -49.567M 30.45% | -51.43M 15.97% | -48.12M -47.67% | -45.408M 13.71% | -36.302M 26.76% | -38.366M 25.40% | -37.907M 21.22% | -40.446M 10.93% | -44.829M -23.49% | -41.371M -7.83% | -38.75M -2.22% | -35.098M 13.22% |
| EBIT Q2Q % growth | -59.803M 26.50% | -59.981M 26.54% | -56.481M 11.85% | -57.31M 7.16% | -53.16M 11.11% | -53.173M 11.35% | -47.342M 16.18% | -51.514M 10.11% | -47.042M 11.51% | -43.544M 18.11% | -40.953M 13.50% | -37.444M 27.31% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 0.51 264.52% | -0.21 | 0.72 | 343.44% |
| Q3 2024 Q2Q % growth | -0.22 15.38% | -0.23 | 0.01 | 3.93% |
| Q2 2024 Q2Q % growth | -0.64 -128.57% | -0.24 | -0.40 | -169.73% |
| Q1 2024 Q2Q % growth | -0.29 19.44% | -0.28 | -0.01 | -3.24% |
| Q4 2023 Q2Q % growth | -0.31 16.22% | -0.29 | -0.02 | -6.56% |
| Q3 2023 Q2Q % growth | -0.26 23.53% | -0.33 | 0.07 | 22.31% |
| Q2 2023 Q2Q % growth | -0.28 12.50% | -0.33 | 0.05 | 14.39% |
| Q1 2023 Q2Q % growth | -0.36 2.70% | -0.34 | -0.02 | -6.15% |
| Q4 2022 Q2Q % growth | -0.37 -19.35% | -0.37 | 0.00 | -0.41% |
| Q3 2022 Q2Q % growth | -0.34 -47.83% | -0.34 | 0.00 | -0.50% |
| Q2 2022 Q2Q % growth | -0.32 -52.38% | -0.33 | 0.01 | 2.97% |
| Q1 2022 Q2Q % growth | -0.37 17.78% | -0.31 | -0.06 | -17.65% |
| Q4 2021 Q2Q % growth | -0.31 -183.78% | -0.29 | -0.02 | -7.27% |
| Q3 2021 Q2Q % growth | -0.23 -64.29% | -0.22 | -0.01 | -3.67% |
| Q2 2021 Q2Q % growth | -0.21 -40.00% | -0.21 | 0.00 | 0.06% |
| Q1 2021 Q2Q % growth | -0.45 -114.29% | -0.47 | 0.02 | 3.67% |
| Q4 2020 Q2Q % growth | 0.37 | 0.32 | 0.05 | 14.07% |
| Q3 2020 Q2Q % growth | -0.14 26.32% | -0.14 | 0.00 | -2.43% |
| Q2 2020 Q2Q % growth | -0.15 6.25% | -0.18 | 0.03 | 18.30% |
| Q1 2020 Q2Q % growth | -0.21 -5.00% | -0.16 | -0.05 | -30.72% |
| Q4 2019 Q2Q % growth | 0.00 | -0.17 | 0.17 | 100.00% |
| Q3 2019 Q2Q % growth | -0.19 | -0.15 | -0.04 | -24.18% |
| Q2 2019 Q2Q % growth | -0.16 | -0.16 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.20 | -0.16 | -0.04 | -29.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 39.224M -32.79% | 40.964M | -1.74M | -4.25% |
| Q3 2024 Q2Q % growth | 39.967M -28.23% | 42.794M | -2.827M | -6.61% |
| Q2 2024 Q2Q % growth | 36.013M -24.30% | 41.695M | -5.682M | -13.63% |
| Q1 2024 Q2Q % growth | 38.81M -0.23% | 43.821M | -5.011M | -11.44% |
| Q4 2023 Q2Q % growth | 58.357M 113.37% | 58.635M | -278K | -0.47% |
| Q3 2023 Q2Q % growth | 55.691M 72.36% | 49.736M | 5.955M | 11.97% |
| Q2 2023 Q2Q % growth | 47.573M 34.12% | 41.104M | 6.469M | 15.74% |
| Q1 2023 Q2Q % growth | 38.9M 17.27% | 35.071M | 3.829M | 10.92% |
| Q4 2022 Q2Q % growth | 27.35M -24.07% | 26.762M | 588K | 2.20% |
| Q3 2022 Q2Q % growth | 32.31M -7.39% | 36.108M | -3.798M | -10.52% |
| Q2 2022 Q2Q % growth | 35.47M 15.88% | 35.863M | -393K | -1.10% |
| Q1 2022 Q2Q % growth | 33.17M 14.38% | 33.476M | -306K | -0.91% |
| Q4 2021 Q2Q % growth | 36.02M 32.72% | 36.842M | -822K | -2.23% |
| Q3 2021 Q2Q % growth | 34.89M 82.86% | 33.898M | 992K | 2.93% |
| Q2 2021 Q2Q % growth | 30.61M 79.22% | 30.589M | 21K | 0.07% |
| Q1 2021 Q2Q % growth | 29M 85.90% | 26.093M | 2.907M | 11.14% |
| Q4 2020 Q2Q % growth | 27.14M -2.83% | 25.92M | 1.22M | 4.71% |
| Q3 2020 Q2Q % growth | 19.08M -12.96% | 20.758M | -1.678M | -8.08% |
| Q2 2020 Q2Q % growth | 17.08M -30.63% | 13.997M | 3.083M | 22.03% |
| Q1 2020 Q2Q % growth | 15.6M -5.05% | 20.47M | -4.87M | -23.79% |
| Q4 2019 Q2Q % growth | 27.93M | 26.032M | 1.898M | 7.29% |
| Q3 2019 Q2Q % growth | 21.92M | 27.576M | -5.656M | -20.51% |
| Q2 2019 Q2Q % growth | 24.62M | 21.228M | 3.392M | 15.98% |
| Q1 2019 Q2Q % growth | 16.43M | 22.076M | -5.646M | -25.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.54% | -1.14% | -8.97% | -8.07% |
| Revenue | 0% | -0.84% | -12.8% | -15.34% |